Share Us:

Biblio

Export 300 results:

Tagged

Author Title Type [ Year

]

Filters: First Letter Of Title is P [Clear All Filters]

2016

R. Penninkilampi, Brothers, H. M., and Eslick, G. D., “Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1395-404, 2016.

W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D., “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.

M. Brody, Liu, E., Di, J., Lu, M., Margolin, R. A., Werth, J. L., Booth, K., Shadman, A., H Brashear, R., and Novak, G., “A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1509-1519, 2016.

A. M. Lozano, Fosdick, L., M Chakravarty, M., Leoutsakos, J. - M., Munro, C., Oh, E., Drake, K. E., Lyman, C. H., Rosenberg, P. B., Anderson, W. S., Tang-Wai, D. F., Pendergrass, J. Cara, Salloway, S., Asaad, W. F., Ponce, F. A., Burke, A., Sabbagh, M., Wolk, D. A., Baltuch, G., Okun, M. S., Foote, K. D., McAndrews, M. Pat, Giacobbe, P., Targum, S. D., Lyketsos, C. G., and Smith, G. S., “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.

C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J., “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.

M. El Haj, Kapogiannis, D., and Antoine, P., “Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 2, pp. 421-31, 2016.

G. Ben-Sadoun, Sacco, G., Manera, V., Bourgeois, J., König, A., Foulon, P., Fosty, B., Bremond, F., d'Arripe-Longueville, F., and Robert, P., “Physical and Cognitive Stimulation Using an Exergame in Subjects with Normal Aging, Mild and Moderate Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1299-314, 2016.

S. Kang, Jeong, H., Baek, J. - H., Lee, S. - J., Han, S. - H., Cho, H. Jin, Kim, H., Hong, H. Seok, Kim, Y. Ho, Yi, E. C., Seo, S. Won, Na, D. L., Hwang, D., and Mook-Jung, I., “PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1563-76, 2016.

H. K. Mohseni, Cowan, D., Chettle, D. R., Milić, A. Pejović, Priest, N., Matysiak, W., Atanackovic, J., Byun, S. Hyun, and Prestwich, W. V., “A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.”, J Alzheimers Dis, vol. 53, no. 3, pp. 933-42, 2016.

N. Marchesi, Amadio, M., Colombrita, C., Govoni, S., Ratti, A., and Pascale, A., “PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.

Y. Xing, Tang, Y., Zhao, L., Wang, Q., Qin, W., Zhang, J. - L., and Jia, J., “Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1029-35, 2016.

P. Chatterjee, Lim, W. L. F., Shui, G., Gupta, V. B., James, I., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., Benzinger, T., Masters, C., Snowden, S. G., Wenk, M. R., Bateman, R. J., Morris, J. C., and Martins, R. N., “Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.”, J Alzheimers Dis, vol. 50, no. 3, pp. 887-94, 2016.

D. Galimberti, Bertram, K., Formica, A., Fenoglio, C., Cioffi, S. M. G., Arighi, A., Scarpini, E., and Colosimo, C., “Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes.”, J Alzheimers Dis, vol. 53, no. 2, pp. 445-9, 2016.

B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., “Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.

I. Luccarini, Pantano, D., Nardiello, P., Cavone, L., Lapucci, A., Miceli, C., Nediani, C., Berti, A., Stefani, M., and Casamenti, F., “The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study.”, J Alzheimers Dis, vol. 54, no. 2, pp. 737-50, 2016.

M. Waragai, Adame, A., Trinh, I., Sekiyama, K., Takamatsu, Y., Une, K., Masliah, E., and Hashimoto, M., “Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1453-9, 2016.

R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., “Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.

R. Smith, Wibom, M., Olsson, T., Hägerström, D., Jögi, J., Rabinovici, G. D., and Hansson, O., “Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.”, J Alzheimers Dis, vol. 51, no. 2, pp. 339-43, 2016.

B. Seok Ye, Lee, Y., Kwak, K., Park, Y. - H., Ham, J. Hyun, Lee, J. Jung, Shin, N. - Y., Lee, J. - M., Sohn, Y. H., and Lee, P. Hyu, “Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1237-43, 2016.

L. Guo, Rezvanian, A., Kukreja, L., Hoveydai, R., Bigio, E. H., Mesulam, M. - M., Khoury, J. El, and Geula, C., “Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-β.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1157-1167, 2016.

T. Yamasaki, Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J. - I., and Tobimatsu, S., “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.

H. E. Barry, Cooper, J. A., Ryan, C., A Passmore, P., A Robinson, L., Molloy, G. J., Darcy, C. M., Buchanan, H., and Hughes, C. M., “Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1503-13, 2016.

K. Ota, Oishi, N., Ito, K., and Fukuyama, H., “Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1385-401, 2016.

L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., “Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.

B. Yoon, Shim, Y. S., Park, H. - K., Park, S. Ah, Choi, S. Hye, and Yang, D. Won, “Predictive factors for disease progression in patients with early-onset Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.

Pages